Cancer Causes & Control

, Volume 21, Issue 1, pp 171–180 | Cite as

trans-Fatty acid consumption and its association with distal colorectal cancer in the North Carolina Colon Cancer Study II

  • Lisa C. VinikoorEmail author
  • Robert C. Millikan
  • Jessie A. Satia
  • Jane C. Schroeder
  • Christopher F. Martin
  • Joseph G. Ibrahim
  • Robert S. Sandler
Original paper


Recently, the potential health effects of trans-fatty acid consumption have raised concerns. A few studies have examined the risk of colorectal cancer with increasing consumption of trans-fatty acids, but none investigated the risk of rectal cancer, which may have different risk factors than colon cancer. Our objective was to explore the relationship between trans-fatty acid consumption and distal colorectal (sigmoid, rectosigmoid, and rectal) cancer using a case–control study of Whites (n = 1,516) and African Americans (n = 392) in North Carolina from 2001 to 2006. Matched cases and controls were interviewed about demographic information, lifestyle factors, and diet. White cases reported higher mean consumption of trans-fatty acid than White controls, but mean consumption was similar for African American cases and controls. Relative to the lowest quartile, the highest quartiles of energy-adjusted trans-fatty acid consumption were positively associated with distal colorectal cancer for Whites [adjusted ORs for the third and fourth quartiles are 1.54 (95%CI: 1.12, 2.13) and 1.45 (95%CI: 1.04, 2.03), respectively]. Consumption was not associated with distal colorectal cancer in African Americans [adjusted ORs for the third and fourth quartiles are 0.98 (95%CI: 0.47, 2.05) and 0.87 (95%CI 0.42, 1.81), respectively]. In conclusion, high consumption of trans-fatty acids was positively associated with distal colorectal cancer among Whites.


Colorectal neoplasms trans-fatty acids Risk factors Case–control studies 



Grant support was received from the National Institutes of Health (P30DK34987, R01CA66635, T32DK07634).


  1. 1.
    Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43–66CrossRefPubMedGoogle Scholar
  2. 2.
    World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. AICR, Washington, DCGoogle Scholar
  3. 3.
    Franco A, Sikalidis AK, Solis Herruzo JA (2005) Colorectal cancer: influence of diet and lifestyle factors. Rev Esp Enferm Dig 97:432–448PubMedCrossRefGoogle Scholar
  4. 4.
    Giovannucci E (2003) Diet, body weight, and colorectal cancer: a summary of the epidemiologic evidence. J Womens Health (Larchmt) 12:173–182CrossRefGoogle Scholar
  5. 5.
    Giovannucci E, Goldin B (1997) The role of fat, fatty acids, and total energy intake in the etiology of human colon cancer. Am J Clin Nutr 66:1564S–1571SPubMedGoogle Scholar
  6. 6.
    Howe GR, Aronson KJ, Benito E et al (1997) The relationship between dietary fat intake and risk of colorectal cancer: evidence from the combined analysis of 13 case–control studies. Cancer Causes Control 8:215–228CrossRefPubMedGoogle Scholar
  7. 7.
    Kushi L, Giovannucci E (2002) Dietary fat and cancer. Am J Med 113:63S–70SCrossRefPubMedGoogle Scholar
  8. 8.
    Slattery ML, Potter JD, Duncan DM, Berry TD (1997) Dietary fats and colon cancer: assessment of risk associated with specific fatty acids. Int J Cancer 73:670–677CrossRefPubMedGoogle Scholar
  9. 9.
    Odegaard AO, Pereira MA (2006) Trans fatty acids, insulin resistance, and type 2 diabetes. Nutr Rev 64:364–372CrossRefPubMedGoogle Scholar
  10. 10.
    Zaloga GP, Harvey KA, Stillwell W, Siddiqui R (2006) Trans fatty acids and coronary heart disease. Nutr Clin Pract 21:505–512CrossRefPubMedGoogle Scholar
  11. 11.
    Bakker N, Van’t Veer P, Zock PL (1997) Adipose fatty acids and cancers of the breast, prostate and colon: an ecological study. EURAMIC Study Group. Int J Cancer 72:587–591CrossRefPubMedGoogle Scholar
  12. 12.
    Lin J, Zhang SM, Cook NR, Lee IM, Buring JE (2004) Dietary fat and fatty acids and risk of colorectal cancer in women. Am J Epidemiol 160:1011–1022CrossRefPubMedGoogle Scholar
  13. 13.
    Nkondjock A, Shatenstein B, Maisonneuve P, Ghadirian P (2003) Assessment of risk associated with specific fatty acids and colorectal cancer among French-Canadians in Montreal: a case–control study. Int J Epidemiol 32:200–209CrossRefPubMedGoogle Scholar
  14. 14.
    Theodoratou E, McNeill G, Cetnarskyj R et al (2007) Dietary fatty acids and colorectal cancer: a case–control study. Am J Epidemiol 166:181–195CrossRefPubMedGoogle Scholar
  15. 15.
    Slattery ML, Benson J, Ma KN, Schaffer D, Potter JD (2001) Trans-fatty acids and colon cancer. Nutr Cancer 39:170–175CrossRefPubMedGoogle Scholar
  16. 16.
    Vinikoor LC, Satia JA, Schroeder JC et al (2009) Associations between trans fatty acid consumption and colon cancer among whites and African Americans in the North Carolina colon cancer study I. Nutr Cancer 61:427--436CrossRefPubMedGoogle Scholar
  17. 17.
    Limburg PJ, Liu-Mares W, Vierkant RA et al (2008) Prospective evaluation of trans-fatty acid intake and colorectal cancer risk in the Iowa Women’s Health Study. Int J Cancer 123:2717–2719CrossRefPubMedGoogle Scholar
  18. 18.
    Pischon T, Lahmann PH, Boeing H et al (2006) Body size and risk of colon and rectal cancer in the European prospective investigation into cancer and nutrition (EPIC). J Natl Cancer Inst 98:920–931PubMedGoogle Scholar
  19. 19.
    Huncharek M, Muscat J, Kupelnick B (2009) Colorectal cancer risk and dietary intake of calcium, vitamin D, and dairy products: a meta-analysis of 26, 335 cases from 60 observational studies. Nutr Cancer 61:47–69CrossRefPubMedGoogle Scholar
  20. 20.
    Jarvinen R, Knekt P, Hakulinen T, Aromaa A (2001) Prospective study on milk products, calcium and cancers of the colon and rectum. Eur J Clin Nutr 55:1000–1007CrossRefPubMedGoogle Scholar
  21. 21.
    Slattery ML (2004) Physical activity and colorectal cancer. Sports Med 34:239–252CrossRefPubMedGoogle Scholar
  22. 22.
    Friedenreich C, Norat T, Steindorf K et al (2006) Physical activity and risk of colon and rectal cancers: the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 15:2398–2407CrossRefPubMedGoogle Scholar
  23. 23.
    Satia-Abouta J, Galanko JA, Potter JD, Ammerman A, Martin CF, Sandler RS (2003) Associations of total energy and macronutrients with colon cancer risk in African Americans and Whites: results from the North Carolina colon cancer study. Am J Epidemiol 158:951–962CrossRefPubMedGoogle Scholar
  24. 24.
    Weinberg CR, Sandler DP (1991) Randomized recruitment in case–control studies. Am J Epidemiol 134:421–432PubMedGoogle Scholar
  25. 25.
    Ainsworth BE, Haskell WL, Whitt MC et al (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32:S498–S504CrossRefPubMedGoogle Scholar
  26. 26.
    Blair SN, Haskell WL, Ho P et al (1985) Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments. Am J Epidemiol 122:794–804PubMedGoogle Scholar
  27. 27.
    Richardson MT, Ainsworth BE, Jacobs DR, Leon AS (2001) Validation of the Stanford 7-day recall to assess habitual physical activity. Ann Epidemiol 11:145–153CrossRefPubMedGoogle Scholar
  28. 28.
    Subar AF, Thompson FE, Kipnis V et al (2001) Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires: the eating at America’s Table Study. Am J Epidemiol 154:1089–1099CrossRefPubMedGoogle Scholar
  29. 29.
    Thompson FE, Subar AF, Brown CC et al (2002) Cognitive research enhances accuracy of food frequency questionnaire reports: results of an experimental validation study. J Am Diet Assoc 102:212–225CrossRefPubMedGoogle Scholar
  30. 30.
    Subar AF, Midthune D, Kulldorff M et al (2000) Evaluation of alternative approaches to assign nutrient values to food groups in food frequency questionnaires. Am J Epidemiol 152:279–286CrossRefPubMedGoogle Scholar
  31. 31.
    Dixon LB, Zimmerman TP, Kahle LL, Subar AF (2003) Adding carotenoids to the NCI Diet History Questionnaire Database. J Food Comp Anal 16:269–280CrossRefGoogle Scholar
  32. 32.
    Willett W, Stampfer MJ (1986) Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 124:17–27PubMedGoogle Scholar
  33. 33.
    Baron JA, Sandler RS (2000) Nonsteroidal anti-inflammatory drugs and cancer prevention. Annu Rev Med 51:511–523CrossRefPubMedGoogle Scholar
  34. 34.
    Mozaffarian D, Pischon T, Hankinson SE et al (2004) Dietary intake of trans fatty acids and systemic inflammation in women. Am J Clin Nutr 79:606–612PubMedGoogle Scholar
  35. 35.
    Vinikoor LC, Schroeder JC, Millikan RC et al (2008) Consumption of trans-fatty acid and its association with colorectal adenomas. Am J Epidemiol 168:289–297CrossRefPubMedGoogle Scholar
  36. 36.
    McKelvey W, Greenland S, Chen MJ et al (1999) A case–control study of colorectal adenomatous polyps and consumption of foods containing partially hydrogenated oils. Cancer Epidemiol Biomarkers Prev 8:519–524PubMedGoogle Scholar
  37. 37.
    McKelvey W, Greenland S, Sandler RS (2000) A second look at the relation between colorectal adenomas and consumption of foods containing partially hydrogenated oils. Epidemiology 11:469–473CrossRefPubMedGoogle Scholar
  38. 38.
    Colandre ME, Diez RS, Bernal CA (2003) Metabolic effects of trans fatty acids on an experimental dietary model. Br J Nutr 89:631–639CrossRefPubMedGoogle Scholar
  39. 39.
    Kuhnt K, Wagner A, Kraft J, Basu S, Jahreis G (2006) Dietary supplementation with 11trans- and 12trans-18:1 and oxidative stress in humans. Am J Clin Nutr 84:981–988PubMedGoogle Scholar
  40. 40.
    O’Keefe SJ (2008) Nutrition and colonic health: the critical role of the microbiota. Curr Opin Gastroenterol 24:51–58CrossRefPubMedGoogle Scholar
  41. 41.
    Reddy BS, Simi B, Patel N, Aliaga C, Rao CV (1996) Effect of amount and types of dietary fat on intestinal bacterial 7 alpha-dehydroxylase and phosphatidylinositol-specific phospholipase C and colonic mucosal diacylglycerol kinase and PKC activities during stages of colon tumor promotion. Cancer Res 56:2314–2320PubMedGoogle Scholar
  42. 42.
    Riserus U (2006) Trans fatty acids and insulin resistance. Atheroscler Suppl 7:37–39CrossRefPubMedGoogle Scholar
  43. 43.
    Bruce WR, Giacca A, Medline A (2000) Possible mechanisms relating diet and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 9:1271–1279PubMedGoogle Scholar
  44. 44.
    Lee DY, Lupton JR, Aukema HM, Chapkin RS (1993) Dietary fat and fiber alter rat colonic mucosal lipid mediators and cell proliferation. J Nutr 123:1808–1817PubMedGoogle Scholar
  45. 45.
    Department of Health and Mental Hygiene Board of Health (2006) Notice of adoption of an amendment (§81.50) to article 81 of the New York City Health CodeGoogle Scholar
  46. 46.
    Okie S (2007) New York to trans fats: you’re out!. N Engl J Med 356:2017–2021CrossRefPubMedGoogle Scholar
  47. 47.
    Food and Drug Administration (2003) Federal register, food labeling; trans fatty acids in nutrition labeling; consumer research to consider nutrient content and health claims and possible footnote or disclosure statements; final rule and proposed rule. National Archives and Records Administration 68:41433–41506Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2009

Authors and Affiliations

  • Lisa C. Vinikoor
    • 1
    • 2
    Email author
  • Robert C. Millikan
    • 1
  • Jessie A. Satia
    • 1
    • 2
    • 3
  • Jane C. Schroeder
    • 1
  • Christopher F. Martin
    • 2
  • Joseph G. Ibrahim
    • 4
  • Robert S. Sandler
    • 2
  1. 1.Department of Epidemiology, School of Public HealthUniversity of North Carolina at Chapel HillChapel HillUSA
  2. 2.Center for Gastrointestinal Biology and Disease, School of MedicineUniversity of North Carolina at Chapel HillChapel HillUSA
  3. 3.Department of Nutrition, School of Public HealthUniversity of North CarolinaChapel HillUSA
  4. 4.Department of Biostatistics, School of Public HealthUniversity of North CarolinaChapel HillUSA

Personalised recommendations